source
- Authors rebut mischaracterization of their 2023 Lancet Covid study in recent op-edThe authors of a 2023 Lancet analysis on the United States Covid response wrote to correct a recent First Opinion piece that they say misrepresented their work. While they welcome calls for additio…
- Sanofi CEO pledges deeper review of late-stage pipeline before Phase 3 movesSanofi's new chief executive, Belén Garijo, announced that the company will examine its late-stage pipeline more closely. The goal is to ensure that data from Phase 2 (or Phase 1b, depending on th…